Effect of Recombinant Human Bone Morphogenetic Protein-2 on Fracture Healing in a Goat Tibial Fracture Model

Abstract

Bone morphogenetic proteins (BMPs) are considered to have important regulatory roles in skeletal embryogenesis and bone healing. Recombinant human BMPs (rhBMPs) have been shown to heal critical size defects and promote spinal fusion. We studied the effects of rhBMP-2 in an absorbable collagen sponge (ACS) on bone healing in a large animal tibial fracture model. Bilateral closed tibial fractures were created in 16 skeletally mature goats and reduced and stabilized using external fixation. In each animal, one tibia received the study device (0.86 mg of rhBMP-2/ACS or buffer/ACS), and the contralateral fracture served as control. The device was implanted as a folded onlay or wrapped circumferentially around the fracture. Six weeks following fracture, the animals were sacrificed and the tibiae harvested for torsional testing and histomorphologic evaluation. Radiographs indicated increased callus at 3 weeks in the rhBMP-2/ACS treated tibiae. At 6 weeks, the rhBMP-2/ACS wrapped fractures had superior radiographic healing scores compared with buffer groups and controls. The rhBMP-2/ACS produced a significant increase in torsional toughness (p ‫؍‬ 0.02), and trends of increased torsional strength and stiffness ( p ‫؍‬ 0.09) compared with fracture controls. The device placed in a wrapped fashion around the fracture produced significantly tougher callus ( p ‫؍‬ 0.02) compared with the onlay application. Total callus new bone volume was significantly increased ( p ‫؍‬ 0.02) in the rhBMP-2/ACS fractures compared with buffer groups and controls regardless of the method of device application. The rhBMP-2/ACS did not alter the timing of onset of periosteal/ endosteal callus formation compared with controls. Neither the mineral apposition rates nor bone formation rates were affected by rhBMP-2/ACS treatment. The increased callus volume associated with rhBMP-2 treatment produced only moderate increases in strength and

Vibrational stimulation induces osteoblast differentiation and the upregulation of osteogenic gene expression in vitro

“…Initially vibration upregulates expression of the osteoblast-specific master gene, Runx2, which leads to increased Osterix expression as the cells differentiate into osteoblast precursors. Runx2 and Osterix transcription factors may regulate subsequent extracellular matrix gene transcription, such as ALP, Col1, BSP, OPN, and OC (Harada et al 1999;Jang et al 2012;Javed et al 2001;Welch et al 1998). Immature osteoblasts then differentiate into mature osteoblasts through matrix production and mineralization (Eriksen 2010).…”

Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells

“…BMP-2 and BMP-7 have further been demonstrated to enhance bone healing in vivo in animals and humans in settings such as spinal fusion, fracture repair and distraction osteogenesis [23][24][25]. Although there appears to be some benefit from the use of BMPs clinically there continues to be uncertainty about the BMP potential since animal and in vitro models have demonstrated much more potent responses than results observed in cultured human cells or in clinical studies.…”

Ankaferd Blood Stopper: Does it have a role in fracture healing?

“…Bone morphogenetic proteins (BMPs), which belong to the TGF-β superfamily, have been implicated in a variety of functions including the formation of both cartilage and bone in skeletal embryogenesis and to be osteoinductive in vitro and in vivo (9). From these BMPs, BMP-2 is produced by mesenchymal cells, osteoblasts, and chondrocytes during fracture healing.…”

“…From these BMPs, BMP-2 is produced by mesenchymal cells, osteoblasts, and chondrocytes during fracture healing. BMP-2 is absolutely required for normal fracture healing (9,10). FGF-2 is recognized as a potent mitogen for a variety of mesenchymal cells.…”